Joel BERNIAC, PhD, MBA: Chief Executive Officer, President and Vice-Chairman of the Board of Managers (and Akrivis Co–Founder), brings over 10 years of experience and expertise in drug discovery and business development in the pharmaceutical industry.
Ban-An KHAW, PhD: Chief Scientific Officer and Chairman of the Board of Managers (and Akrivis Co–Founder), brings over 40 years of experience and expertise in immunology, immunoassay development, nuclear medicine, nuclear molecular cardiology and targeted drug delivery.
Christopher SCANNELL, MBA: Chief Business Officer, brings over 20 years of experience and expertise in business development, strategic partnerships, technology licensing and new proteomics and genomics technology platform development as an executive in the diagnostics, medical devices, pharmaceutical and biotechnology industries.
George HILLMAN, MBA: Chief Financial Officer, brings over 25 years of experience in business development and corporate financing, with a specialty on initial and follow-on start-up financing rounds in the Pharma, Biotech, Diagnostics and Medical Device industries. With an extensive executive experience in management and operations (ex-CEO at Pintex Pharma, ex-COO at Cohesive Technologies and Paratek Pharmaceuticals), George has raised over $100 Million in cumulated capital, negotiated 10 licenses and 12 research agreements, and closed 3 sale/merge deals.